Kelly Paul Edward bought RLMD

November 5, 2025 · Form 4 insider transaction

Kelly Paul Edward bought 90,000 shares of Relmada Therapeutics, Inc. at $2.20 per share, a transaction worth $198.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.